Paratek Pharmaceuticals' Series A Round

Paratek Pharmaceuticals raised a round of funding on April 01, 1999.

Paratek is a biopharmaceutical company focused on the development, and commercialization of innovative antibiotics. Paratek's lead product candidate, omadacycline, is a novel tetracycline-derived, bro…

Articles about Paratek Pharmaceuticals' Series A Round: